{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# First implementation of a GNN (GCN)\n",
    "In this notebook, we build the graph from an initial dataframe, and we execute the first implementation of our GNN, which contains 1 convolutive layer and 1 fully-connected layer.\n",
    "\n",
    "## Notebook plan : \n",
    "1. Building the graph\n",
    "2. Building the GCN"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "from models.BuildGraph import BuildGraph"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Building the graph\n",
    "Here, we split the patients by tumour type. We merge tumour types if they contain only 1 patient."
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Reading the dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Anonymous ID</th>\n",
       "      <th>EGA ID</th>\n",
       "      <th>Tumour type</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Line of therapy</th>\n",
       "      <th>Immunotherapy regimen</th>\n",
       "      <th>Cohort</th>\n",
       "      <th>Reason for discontinuation</th>\n",
       "      <th>Best response</th>\n",
       "      <th>Age at advanced disease diagnosis</th>\n",
       "      <th>...</th>\n",
       "      <th>Alive_0</th>\n",
       "      <th>Time to progression (days)</th>\n",
       "      <th>Progression_1</th>\n",
       "      <th>Clinical benefit</th>\n",
       "      <th>CD8+ T cell score</th>\n",
       "      <th>Exome mut per mb</th>\n",
       "      <th>Genome mut per mb</th>\n",
       "      <th>CD274 expression</th>\n",
       "      <th>M1M2 expression</th>\n",
       "      <th>Lymph related</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>14891</td>\n",
       "      <td>EGAD00001001961</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>8</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Mixed</td>\n",
       "      <td>45</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>179</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.351869</td>\n",
       "      <td>11.095310</td>\n",
       "      <td>23.0729</td>\n",
       "      <td>4.1689</td>\n",
       "      <td>55.51575</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>18624</td>\n",
       "      <td>EGAD00001002047</td>\n",
       "      <td>AECA</td>\n",
       "      <td>F</td>\n",
       "      <td>10</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>47</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>148</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.071464</td>\n",
       "      <td>3.876336</td>\n",
       "      <td>5.4552</td>\n",
       "      <td>0.7910</td>\n",
       "      <td>9.32352</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>21392</td>\n",
       "      <td>EGAD00001002544</td>\n",
       "      <td>OV</td>\n",
       "      <td>F</td>\n",
       "      <td>6</td>\n",
       "      <td>Monalizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>57</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>79</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.040394</td>\n",
       "      <td>2.415688</td>\n",
       "      <td>4.1274</td>\n",
       "      <td>4.0377</td>\n",
       "      <td>50.12008</td>\n",
       "      <td>Lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>21516</td>\n",
       "      <td>EGAD00001002546</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Ipilimumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Not evaluable</td>\n",
       "      <td>29</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>11</td>\n",
       "      <td>0</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.052774</td>\n",
       "      <td>6.235845</td>\n",
       "      <td>11.4871</td>\n",
       "      <td>0.6006</td>\n",
       "      <td>1.58550</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>22186</td>\n",
       "      <td>EGAD00001001966</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>4</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>52</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>80</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.009323</td>\n",
       "      <td>4.606660</td>\n",
       "      <td>7.1503</td>\n",
       "      <td>1.8234</td>\n",
       "      <td>38.42695</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>39280</td>\n",
       "      <td>EGAD00001004933</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Toxicity</td>\n",
       "      <td>Physician Assessed SD</td>\n",
       "      <td>60</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>401</td>\n",
       "      <td>0</td>\n",
       "      <td>DCB</td>\n",
       "      <td>0.695396</td>\n",
       "      <td>84.998501</td>\n",
       "      <td>96.4079</td>\n",
       "      <td>8.4768</td>\n",
       "      <td>86.62561</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>37899</td>\n",
       "      <td>EGAD00001005838</td>\n",
       "      <td>CHOL</td>\n",
       "      <td>F</td>\n",
       "      <td>2</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Physician assessed PR</td>\n",
       "      <td>38</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>96</td>\n",
       "      <td>0</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.818233</td>\n",
       "      <td>2.247151</td>\n",
       "      <td>2.7416</td>\n",
       "      <td>11.2704</td>\n",
       "      <td>47.97376</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>37775</td>\n",
       "      <td>EGAD00001004934</td>\n",
       "      <td>HNSC</td>\n",
       "      <td>M</td>\n",
       "      <td>1</td>\n",
       "      <td>Avelumab/OX40 agonist PF-04518600</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>69</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>69</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.018982</td>\n",
       "      <td>3.848247</td>\n",
       "      <td>5.8036</td>\n",
       "      <td>8.7136</td>\n",
       "      <td>5.13403</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>38313</td>\n",
       "      <td>EGAD00001005844</td>\n",
       "      <td>ACC</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Avelumab/Debio1143 (SMAC mimetic)</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Toxicity</td>\n",
       "      <td>Partial response</td>\n",
       "      <td>34</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>51</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>5.617878</td>\n",
       "      <td>7.7940</td>\n",
       "      <td>0.0688</td>\n",
       "      <td>0.51364</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>38207</td>\n",
       "      <td>EGAD00001005850</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>1</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>50</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>104</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.110416</td>\n",
       "      <td>33.763449</td>\n",
       "      <td>53.2769</td>\n",
       "      <td>23.8818</td>\n",
       "      <td>11.22022</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>82 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Anonymous ID           EGA ID Tumour type Sex Line of therapy   \n",
       "0          14891  EGAD00001001961        LUNG   F               8  \\\n",
       "1          18624  EGAD00001002047        AECA   F              10   \n",
       "2          21392  EGAD00001002544          OV   F               6   \n",
       "3          21516  EGAD00001002546        SKCM   F               3   \n",
       "4          22186  EGAD00001001966        LUNG   F               4   \n",
       "..           ...              ...         ...  ..             ...   \n",
       "92         39280  EGAD00001004933        LUNG   M               2   \n",
       "94         37899  EGAD00001005838        CHOL   F               2   \n",
       "95         37775  EGAD00001004934        HNSC   M               1   \n",
       "96         38313  EGAD00001005844         ACC   F               3   \n",
       "97         38207  EGAD00001005850        LUNG   F               1   \n",
       "\n",
       "                Immunotherapy regimen Cohort Reason for discontinuation   \n",
       "0                           Nivolumab  Naive                Progression  \\\n",
       "1                           Nivolumab  Naive                Progression   \n",
       "2                         Monalizumab  Naive                Progression   \n",
       "3                          Ipilimumab  Naive                      Death   \n",
       "4                        Atezolizumab  Naive                Progression   \n",
       "..                                ...    ...                        ...   \n",
       "92                      Pembrolizumab  Naive                   Toxicity   \n",
       "94                          Nivolumab  Naive                      Death   \n",
       "95  Avelumab/OX40 agonist PF-04518600  Naive                Progression   \n",
       "96  Avelumab/Debio1143 (SMAC mimetic)  Naive                   Toxicity   \n",
       "97                      Pembrolizumab  Naive                Progression   \n",
       "\n",
       "            Best response  Age at advanced disease diagnosis  ...  Alive_0   \n",
       "0                   Mixed                                 45  ...        1  \\\n",
       "1          Stable disease                                 47  ...        1   \n",
       "2   Physician assessed SD                                 57  ...        1   \n",
       "3           Not evaluable                                 29  ...        1   \n",
       "4          Stable disease                                 52  ...        1   \n",
       "..                    ...                                ...  ...      ...   \n",
       "92  Physician Assessed SD                                 60  ...        1   \n",
       "94  Physician assessed PR                                 38  ...        1   \n",
       "95         Stable disease                                 69  ...        1   \n",
       "96       Partial response                                 34  ...        1   \n",
       "97  Physician assessed SD                                 50  ...        0   \n",
       "\n",
       "    Time to progression (days)  Progression_1  Clinical benefit   \n",
       "0                          179              1               NCB  \\\n",
       "1                          148              1               NCB   \n",
       "2                           79              1               NCB   \n",
       "3                           11              0               NCB   \n",
       "4                           80              1               NCB   \n",
       "..                         ...            ...               ...   \n",
       "92                         401              0               DCB   \n",
       "94                          96              0               NCB   \n",
       "95                          69              1               NCB   \n",
       "96                          51              1               NCB   \n",
       "97                         104              1               NCB   \n",
       "\n",
       "   CD8+ T cell score  Exome mut per mb  Genome mut per mb  CD274 expression   \n",
       "0           0.351869         11.095310            23.0729            4.1689  \\\n",
       "1           0.071464          3.876336             5.4552            0.7910   \n",
       "2           0.040394          2.415688             4.1274            4.0377   \n",
       "3           0.052774          6.235845            11.4871            0.6006   \n",
       "4           0.009323          4.606660             7.1503            1.8234   \n",
       "..               ...               ...                ...               ...   \n",
       "92          0.695396         84.998501            96.4079            8.4768   \n",
       "94          0.818233          2.247151             2.7416           11.2704   \n",
       "95          0.018982          3.848247             5.8036            8.7136   \n",
       "96          0.000000          5.617878             7.7940            0.0688   \n",
       "97          0.110416         33.763449            53.2769           23.8818   \n",
       "\n",
       "    M1M2 expression      Lymph related  \n",
       "0          55.51575  Non-lymph related  \n",
       "1           9.32352  Non-lymph related  \n",
       "2          50.12008      Lymph related  \n",
       "3           1.58550  Non-lymph related  \n",
       "4          38.42695  Non-lymph related  \n",
       "..              ...                ...  \n",
       "92         86.62561  Non-lymph related  \n",
       "94         47.97376  Non-lymph related  \n",
       "95          5.13403  Non-lymph related  \n",
       "96          0.51364  Non-lymph related  \n",
       "97         11.22022  Non-lymph related  \n",
       "\n",
       "[82 rows x 21 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_excel('data/Supplemental-table1.xlsx')\n",
    "df = df.loc[df[\"Cohort\"] == \"Naive\"]\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "buildgraph = BuildGraph(df)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Compute the adjacency matrix"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[0., 0., 0., ..., 0., 0., 1.],\n",
       "       [0., 0., 0., ..., 0., 0., 0.],\n",
       "       [0., 0., 0., ..., 0., 0., 0.],\n",
       "       ...,\n",
       "       [0., 0., 0., ..., 0., 0., 0.],\n",
       "       [0., 0., 0., ..., 0., 0., 0.],\n",
       "       [1., 0., 0., ..., 0., 0., 0.]])"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "buildgraph.compute_adjacency_matrix(\"Tumour type\")\n",
    "display(buildgraph.A)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Build the graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "features_label = [\"CD8+ T cell score\",\"Exome mut per mb\"]\n",
    "y_label = [\"Clinical benefit\"]\n",
    "\n",
    "buildgraph.create_graph(features_label, y_label)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Show the graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x700 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "buildgraph.show_graph(\"Graph with split per tumour type\",\"tumour-type.png\")"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Building the GCN"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Formatting data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "tensor([[[[0.9233, 0.2057, 0.2704],\n",
      "          [0.5437, 0.8418, 0.4488],\n",
      "          [0.3578, 0.4455, 0.1678],\n",
      "          [0.4189, 0.2319, 0.8284],\n",
      "          [0.8293, 0.8863, 0.0125]],\n",
      "\n",
      "         [[0.2591, 0.2626, 0.8671],\n",
      "          [0.0211, 0.6352, 0.8176],\n",
      "          [0.7242, 0.7078, 0.5726],\n",
      "          [0.3382, 0.8159, 0.2419],\n",
      "          [0.1908, 0.8088, 0.0832]]],\n",
      "\n",
      "\n",
      "        [[[0.0884, 0.6098, 0.6256],\n",
      "          [0.0903, 0.6613, 0.8076],\n",
      "          [0.2723, 0.7662, 0.6548],\n",
      "          [0.8481, 0.5062, 0.2261],\n",
      "          [0.1469, 0.0163, 0.1051]],\n",
      "\n",
      "         [[0.8890, 0.6551, 0.5036],\n",
      "          [0.9328, 0.6075, 0.8558],\n",
      "          [0.8007, 0.4049, 0.5326],\n",
      "          [0.6983, 0.7300, 0.8832],\n",
      "          [0.3239, 0.2466, 0.6543]]]])\n"
     ]
    }
   ],
   "source": [
    "import torch\n",
    "x = torch.rand(2, 2, 5, 3)\n",
    "print(x)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.6"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
